← Eichor
Study identifier: NCT05067764 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease

Condition: Dupuytren's Disease  ·  Sponsor: Elsan

PhaseNA
Planned participants172
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Dupuytren's disease is a frequent hereditary disease in Northern Europe. It is a degenerative disease affecting the palmar aponeurosis of the hand. It develops a progressive contractile fibrosis which cuts the hypodermic fatty tissue, adheres to the skin and the phalanges, gradually bending the affected rays, resulting in significant functional impotence. Various medical and surgical treatments are available.

This description comes directly from the study's public registry record.

Talk to the study team

Elias SAWAYA, MD  ·  (0)663420278  ·  esawaya.md@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Institut Aquitain de la MainPessac, FranceRecruiting
Santé Atlantique ELSANSaint-Herblain, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05067764